YARW 8-K: SEC filing
Yarrow Bioscience, Inc.
Filed with the SEC on · accession 0001566044-26-000017
YARW filed a 8-K (current report) with the SEC on Nov 12, 2026. Yarrow Bioscience, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026.
Summary of the filing
Yarrow Bioscience, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026. The press release was furnished as Exhibit 99.1 to the Form 8-K.
Key details
✦ Ask GOAX AI about this filing — what it means for YARW, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for YARW?
Click hereFrequently asked questions
What did YARW file with the SEC on Nov 12, 2026?
YARW filed a 8-K (SEC filing). Yarrow Bioscience, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026. The press release was furnished as Exhibit 99.1 to the Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other YARW SEC filings
Get alerts when YARW files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days